The global rate of prostate cancer among men is set to double to 2.9 million annually by 2040, followed by an 85 per cent increase in yearly deaths. Prostate cancer, already a leading cause of mortality, constitutes the most common form of male cancer in over 100 nations.

Prostate cancer cases worldwide expected to double by 2040

Chris Low of FTN Financial said the markets were in wait-and-see mode with a much-anticipated speech from Federal Reserve Chair Janet Yellen

Medivation surges on Pfizer takeover as US markets stay flat

prostate-cancer-medication

Prostate Cancer Medication, News on Prostate Cancer Medication, stories on Prostate Cancer Medication, articles on Prostate Cancer Medication, Prostate Cancer Medication stories at Wion, Prostate Cancer Medication news, Prostate Cancer Medication latest news

prostate cancer-medication

Prostate cancer cases worldwide expected to double by 2040

Medivation surges on Pfizer takeover as US markets stay flat